|Número de publicación||US4458696 A|
|Tipo de publicación||Concesión|
|Número de solicitud||US 06/203,681|
|Fecha de publicación||10 Jul 1984|
|Fecha de presentación||3 Nov 1980|
|Fecha de prioridad||7 Ago 1979|
|Número de publicación||06203681, 203681, US 4458696 A, US 4458696A, US-A-4458696, US4458696 A, US4458696A|
|Inventores||Franklin C. Larimore|
|Cesionario original||Minnesota Mining And Manufacturing Company|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (21), Citada por (143), Clasificaciones (12)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
This application is a continuation-in-part of co-pending application Ser. No. 64,576 filed Aug. 7, 1979, now abandoned, which is a continuation-in-part of application Ser. No. 22,469, filed Mar. 21, 1979, now abandoned.
This invention relates to the field of "dry", disposable biomedical electrodes. More particularly, it relates to dry, disposable biomedical electrodes for transcutaneous electrical nerve stimulation.
Transcutaneous electrical nerve stimulation (T.E.N.S.) is a procedure in which an electrical signal is transmitted through the skin to appropriate underlying nerves where it helps prevent pain signals from reaching the brain. T.E.N.S. has been used for about ten years in major hospitals, medical schools and pain clinics with good results. It is a very desirable method of pain control because it is safe, effective, non-invasive, non-narcotic and has no known side effects.
T.E.N.S. requires the placement of an electrode on the body at the site of stimulation to deliver the electrical signal to the skin beneath the electrode. Typically, the electrode will consist of a connector having means for attachment of a lead wire and a relatively flat, body-conformable, electrical impulse-distribution portion. Metallic foils or conductive plastics are commonly used to fabricate the connector. The connector is attached via the lead wire to a stimulator. To enhance electrical conductivity between the connector and the skin and to reduce the likelihood of "hot spots" developing, a conformable, electrically-conductive interface material is applied between the skin and the connector. The traditional interface material is a conductive gel or a pad saturated with a conductive gel. The gel or gel pad is applied to the skin and overlaid with the connector. An adhesive patch is generally required to hold the electrode in place. This type of electrode assembly suffers from a number of disadvantages. Firstly, conductive gels are predominately water and tend to dry out within a relatively short time after application to the skin and lose their conductivity. This necessitates removal of the electrode and re-application of gel on a daily basis. Secondly, the skin often becomes irritated from the repeated removal of the adhesive patch holding the electrode in place.
These problems were alleviated somewhat by replacing gel with a dry, electrically-conductive interface material, such as plasticized karaya gum, which does not dry out during use. However, karaya gum pads have low adhesion, and an adhesive patch is sometimes required to hold the electrode assembly on the skin. The adhesive patch restricts the movement of the underlying skin and causes a great deal of discomfort to the wearer over prolonged periods of use. Since T.E.N.S. is used for the management of chronic pain, prolonged application of an electrode, e.g., two to seven days, is desirable.
The need has developed for a disposable T.E.N.S. electrode which (1) is economical; (2) does not dry out during use; (3) is self-adhering; and (4) is extensible with the skin.
The prior art has provided T.E.N.S. electrodes meeting one or more of the aforementioned criteria, but has been unsuccessful in providing an electrode meeting all of them. For example, U.S. Pat. Nos. 4,008,721, 4,067,342 and 4,141,366 disclose dry, self-adhering stimulating electrodes wherein the interface layers are pressure-sensitive adhesive materials rendered conductive by the inclusion of conductive metallic particles. These electrodes contain non-woven fabric backings which limit the ability of the electrodes to move with the skin.
U.S. Pat. No. 4,066,078 discloses stimulating electrodes wherein the interface material is an electrically-conductive adhesive comprising certain organic polymers plasticized with a polyhydric alcohol. In the electrode described in U.S. Pat. No., 4,125,110, the conductive interface material is a mixture of a natural organic polysaccharide, such as karaya gum, and a polyhydric alcohol. The interfacing layers in the aforementioned two electrodes are bonded to a metallic foil. The foil is not extensible and restricts the extensibility of the interfacing layer. Furthermore, the interfacing layer in both electrodes is quite thick and too costly to provide a practical, low-cost disposable T.E.N.S. electrode.
The T.E.N.S. electrode of the present invention provides a combination of desirable features heretofore unavailable. In addition to having a "dry" conductive interface layer, which can be used for a period of days without drying out, the thickness of the layer is kept at a minimum to provide a low-cost, disposable electrode. The unique backing layer of the electrode, in combination with the interface layer and the low profile connector, provide an extensible electrode that stretches with the skin and can be worn for long periods, without discomfort or irritation, even over skin areas undergoing constant stretching, e.g., lower back.
According to the present invention, there is provided a T.E.N.S. electrode comprising a dry bodyconformable, electrically-conductive interfacing layer having a maximum thickness of about 10 mils (254 micrometers). The interfacing layer has an adherent top surface and a lower body-contacting surface adapted for adherence to the skin. For connecting the electrode to an electrical stimulator, there is provided a one-piece, body-conformable electrically-conductive connector having a substantially flat electrical impulse-distribution protion, the lower surface of which is adhered to the top surface of the interfacing layer. The upper surface of the connector has means for connection to an electrical stimulator. A backing member is preferably adhered to the upper surface of the interfacing layer to enhance the mechanical integrity of the electrode. It is also preferred that the backing cover all or a portion of the top surface of the connector to prevent displacement of the connector from the interfacing layer during use. When the backing member is adhered to a substantial portion of the upper surface of the connector to hold it in place on the interfacing member, lateral access for connection with the stimulator is provided, or the backing may have a hole therethrough allowing access for the lead wire. The T.E.N.S. electrode of the present invention is extensible in at least one direction up to 50 percent and requires less than about 25×106 dynes/cm2 for an elongation of 20% as tested per ASTM standard D-882.
FIG. 1 is a perspective view of one embodiment the T.E.N.S. electrode of the present invention.
FIG. 2 is an enlarged cross-sectional view of the electrode of FIG. 1 through line 2--2.
FIG. 3 is a perspective view of the interfacing layer and attached backing of the electrode of FIG. 1.
FIG. 4 is a cross-sectional view of the electrode of FIG. 3 through line 4--4.
FIG. 5 is a perspective view of an alternative embodiment of the electrode of the present invention.
FIG. 6 is a fragmented side view of the electrode of FIG. 5.
FIG. 7 is an end view of the electrode of FIG. 6.
FIG. 8 is a side view of a second alternative embodiment of the electrode of the present invention.
Referring to the drawing wherein like reference characters designate like or corresponding elements and referring particularly to FIG. 1, the T.E.N.S. electrode 10 is comprised of a one-piece electrically-conductive connector 16 and a dry, body-conformable, electrically-conductive interfacing layer 11 having a top surface and a lower body-contacting surface adapted for adherence to the skin.
Interfacing layer 11 is thin, i.e., 10 mils (254 micrometers) or less, and preferably 3 to 7 mils (76-178 micrometers). It also exhibits extensibility which is similar to skin. Extensibility is used herein to mean the ability to stretch in at least one direction in a manner which is similar to human skin. Skin is a very extensible material which stretches 20% to 30% during normal activities and up to 50% if needed. Skin is also resilient which allows it to return to an unstretched condition when stress is removed. The preferred interfacing layer 11 is comprised of a carrier portion 12, coated with an electrically conductive adhesive 13. Carrier portion 12 may be comprised of a mat of separate fibers bonded together, e.g. a nonwoven web, which is body-conformable and extensible. The fibers may be polyester, nylon or a cellulosic derivative, e.g., rayon, paper, etc. Carrier portion 12 may also be of a woven structure if the weave allows for the needed extensibility and adhesive impregnation. The ability of a woven or nonwoven structure to allow for impregnation of the conductive adhesive enables the adhesive 13 to conduct the electrical impulse evenly throughout the interfacing layer 11. The preferred material for carrier portion 12 is Crystex™ paper tissue, manufactured by Crystal Paper Co., Middletown, Ohio. Carrier portion 12 imparts a measure of mechanical strength to the construction and may be omitted if the conductive adhesive layer 13 has sufficient strength and extensibility to maintain integrity during use.
In addition to being electrically-conductive, adhesive 13 should exhibit sufficient tack to adhere to the skin. The preferred adhesive 13 is comprised of 75:25 butyl acrylate-acrylic acid copolymer neutralized to 95 mole percent with methyl diethanolamine to which 20 parts/100 parts copolymer and 30 parts/100 parts copolymer of a water-soluble plasticizer and a water-soluble tackifier, respectively, are added as described in U.S. Pat. No. 3,065,770. The resultant adhesive composition preferably is coated onto both sides of the carrier portion 12 at 9.2 micrograms/cm2 (dry basis) to form the interfacing layer 11.
It is contemplated that other polymeric adhesives such as those disclosed in U.S. Pat. Nos. 4,067,342, 3,911,906, 4,054,714 and 3,994,302 may be utilized in interfacing members of the present invention.
Optionally attached to the top surface of interfacing layer 11 is a backing member 14 which, in the embodiment of FIGS. 1-4, has a hole 15 therethrough which allows access to the top surface of the interfacing layer 11. The backing member 14 acts to maintain the integrity of the interfacing layer 11 by covering all of its surface except the hole 15 when the electrode 10 is positioned on the wearer. Backing member 14 must exhibit sufficient extensibility to be complaint with interfacing layer 11 after electrode 10 is placed on the wearer. The preferred material for backing member 14 is a vinyl foam tape sold under the trade name of "Microfoam" Tape, 3M Company, St. Paul, Minnesota 55101. Other suitable materials which may be used to form the backing member include a compressed polyurethane foam sold under the trade name of "Scott Felt", Scott Foam Division, Scott Paper Company, Eddystone, Pennsylvania or a closed cell polyethylene foam, sold under the trade name of "Volara", Voltex Corporation, Lawrence, Massachusetts.
Backing member 14 may be omitted resulting in a biomedical electrode constituted of the interfacing layer 11 and body-conformable connector 16 (discussed below). With this alternative construction, it is preferable that connector 16 cover the entire top surface of interfacing layer 11 to prevent foreign matter from adhering to the top surface of the interfacing layer 11.
For the present invention, a body-conformable, one-piece electrically conductive connector 16 connects the interfacing layer 11 to the electrical stimulator. Connector 16 is comprised of a substantially flat electrical impulse distribution portion having a flat lower surface adapted to fit within hole 15 of backing member 14 in electrical contact with the interfacing layer 11. Connector 16 also is provided with an upper surface having an adapter 18 for connection to the connector lead of an electrical stimulator (not shown). The connector is preferably made of a carbon-impregnated silicone rubber (Silicone Rubber Compound C-968, SWS Silicones Corporation, Adrian, Michigan 49221). Other suitable carbon-impregnated polymeric materials include plasticized polyvinyl chloride, epichlorohydrin rubber, polyurethane molding compound, polytetrafluorethylene and a polymer of ethylene-propylene-diene (e.g. EPDM rubber).
If the backing layer 14 is omitted from the electrode and the connector covers substantially the entire upper surface of the interfacing layer, the connector must have sufficient extensibility to enable the electrode to achieve the requisite extensibility, i.e., up to 50 percent elongation in one direction and requiring less than about 25×106 dynes/cm2 for elongation of 20% as tested in ASTM standard D-882.
An additional feature of connector 16 is that it is releasably attached to interface layer 11 and can be reused.
Referring to FIG. 4, an optional release liner 17 may be attached to the lower surface of the interfacing layer 11 in order to preserve its adhesive character until it is ready for use. Such release liners are well known to the art.
To use the biomedical electrode assembly of the present invention, the release liner 17 is removed and the electrode is placed on the desired surface of the skin. Prior to placing the electrode to the skin, the skin or the lower surface of the interfacing layer 11 may be wetted with water to optimize the adherence and conductivity of the adhesive. The connector, which has been previously attached to the lead of the electrical stimulator, is then releasably adhered to the upper surface of the interfacing layer 11 through hole 15. When stimulation is complete, the connector is removed and may be preserved, while the disposable portion comprising the interfacing layer 11 and the attached backing 14 may be discarded.
Referring to FIGS. 5 through 8, alternative embodiments 20 and 30 may be made without departing from the spirit of the present invention. The alternative embodiments 20 and 30 are also comprised of an optional release liner 17, an interfacing layer 11 and an optional backing member 14A. Connectors 21 and 31 of embodiments 20 and 30, respectively, likewise comprise a one-piece construction having means for connection with an electrical stimulator 18 and a flat electrical impulse distribution portion for electrical contact with interfacing layer 11.
Connectors 21 and 31 differ from connector 16 of electrode 10 in that they are elongated rather than circular. It has been found that in certain use situations, movement of the patient may cause the connector 16 of embodiment 10 to become separated from interfacing layer 11. By overlaying a portion of backing 14A on the top surface of connector 21 or 31 this problem is substantially eliminated.
In order to facilitate the placement of connector 21 or 31, an additional double-sided release liner (not shown) may be placed between a portion of the backing member 14 and the interfacing layer 11. This double-sided release liner may then be removed and connector 21 or 31 positioned on interfacing layer 11 as shown in FIG. 5 or 8. Backing member 14A is then positioned so as to releasably adhere to at least a portion of the top surface of connector 21 or 31 and interfacing layer 11 so as to insure electrical contact between connector 21 or 31 and interfacing layer 11.
Electrode 20 as shown in FIG. 5 is the presently preferred embodiment of the T.E.N.S. electrode of the invention. The top surface of connector 21 is completely covered by backing member 14A. The connector may be removed, if desired, after the initial use for later reuse, but it is contemplated that, in most cases, the entire electrode will be discarded after removal from the body.
It has been found that when electrodes of the invention are applied to the skin, both the underlying skin and the overlying electrode are extended by the same forces acting upon the skin. Since the electrode stretches with the skin, stress and strain on the skin is so insignificant as to be virtually unnoticeable. A dramatic reduction in discomfort and irritation is possible over prior art T.E.N.S. electrodes.
Elongation relaxation tests were run on human skin utilizing methods described in the book by R. M. Kenedi, T. Gibson and C. H. Daly "Structure and Function of Connective and Skeletal Tissue", London: Butterworths 1965 at page 388. It was found that when the skin was retained in a stressed condition, it exhibits a relaxation whereby the force required to maintain the same stress condition gradually declines. Test runs on electrodes of the present invention in accordance with ASTM test D-882 indicate that for an electrode to have elongation and relaxation properties similar to skin, it must preferably (1) be extensible in at least one direction up to 50 percent and (2) require less than about 25×106 dynes/cm2 for an elongation of 20%. Furthermore, it should exhibit a stress relaxation with time when elongated 20% of from about 10% to 20% after 1 minute and about 20% to about 50% after 10 minutes. The electrodes of the present invention exhibit this stress relaxation with time and have sufficient relaxation properties to recover to near their original unstressed length when all stress is removed.
The preferred embodiment of the electrode of the invention as illustrated in FIG. 5 (constructed of the preferred materials described hereinabove) was tested (with release liner 17 removed) according to ASTM test D-882. The results are set forth in the following Tables I and II.
TABLE I*______________________________________ FORCE DYNES/ LBS/INElongation P.S.I. cm2 × 106 WIDTH DYNE/cm × 104______________________________________ 5% 26.86 1.85 0.94 16.4610% 32.29 2.23 1.13 19.7820% 41.14 2.84 1.44 25.21______________________________________ Stress relaxation results were as follows at 20% elongation
TABLE II*______________________________________ (D/cm2 × LBS/IN (D/cm × DE-TIME P.S.I. 106) WIDTH 104) CREASE______________________________________0 41.14 2.84 1.44 25.211 min 15.43 1.06 0.54 9.45 62%______________________________________ *The two flat sides of the electrodes (as contrasted to the sides having the exposed connector) were inserted into the jaws of the "Instron" machine.
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US3566860 *||20 Dic 1968||2 Mar 1971||United Aircraft Corp||Carbon-impregnated body electrode|
|US3599629 *||28 Ago 1968||17 Ago 1971||Lexington Instr||Oxidized surface biopotential skin electrode|
|US3659614 *||29 Dic 1969||2 May 1972||Jankelson Bernard||Adjustable headband carrying electrodes for electrically stimulating the facial and mandibular nerves|
|US3865770 *||1 Dic 1972||11 Feb 1975||Minnesota Mining & Mfg||Water-dispersible pressure-sensitive adhesive, tape made therewith, and novel tackifiers therefor|
|US3911906 *||24 Abr 1974||14 Oct 1975||Survival Technology||Dry applied and operably dry electrode device|
|US3976055 *||27 Nov 1974||24 Ago 1976||Ndm Corporation||Electrode and conductor therefor|
|US3993049 *||26 Dic 1974||23 Nov 1976||Kater John A R||Electrodes and materials therefor|
|US3994302 *||14 Ago 1975||30 Nov 1976||Medtronic, Inc.||Stimulation electrode of ion-exchange material|
|US3998215 *||23 Abr 1971||21 Dic 1976||Minnesota Mining And Manufacturing Company||Bio-medical electrode conductive gel pads|
|US4008721 *||14 Abr 1975||22 Feb 1977||Medtronic, Inc.||Tape electrode for transmitting electrical signals through the skin|
|US4016869 *||30 Oct 1975||12 Abr 1977||Siemens Aktiengesellschaft||Signal collector system|
|US4051842 *||15 Sep 1975||4 Oct 1977||International Medical Corporation||Electrode and interfacing pad for electrical physiological systems|
|US4054714 *||7 Jun 1976||18 Oct 1977||E. I. Du Pont De Nemours And Company||Electrically conductive adhesive composition|
|US4067342 *||6 Abr 1976||10 Ene 1978||Medtronic, Inc.||Tape electrode|
|US4125110 *||7 Nov 1977||14 Nov 1978||Hymes Alan C||Monitoring and stimulation electrode|
|US4141366 *||18 Nov 1977||27 Feb 1979||Medtronic, Inc.||Lead connector for tape electrode|
|US4248247 *||28 Jun 1979||3 Feb 1981||Med General, Inc.||Low cost post-operative electrode|
|US4273135 *||8 Sep 1978||16 Jun 1981||Minnesota Mining And Manufacturing Company||Biomedical electrode|
|DE2727822A1 *||21 Jun 1977||4 Ene 1979||Peter Zimmer||Medical electric skin stimulation electrode - has porous and foil layers joined by adhesive, forming space for liberated gases|
|DE2814061A1 *||31 Mar 1978||5 Oct 1978||Sony Corp||Koerperelektrode|
|EP0000759A1 *||31 Jul 1978||21 Feb 1979||Siemens Aktiengesellschaft||Electrode|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US4633879 *||16 Nov 1979||6 Ene 1987||Lec Tec Corporation||Electrode with disposable interface member|
|US4708149 *||27 Ene 1986||24 Nov 1987||Jens Axelgaard||Electrical stimulation electrode|
|US4715382 *||1 Ago 1986||29 Dic 1987||Minnesota Mining And Manufacturing Company||Flat biomedical electrode with reuseable lead wire|
|US4727880 *||1 Ago 1986||1 Mar 1988||Minnesota Mining And Manufacturing Company||Flat, conformable, biomedical electrode|
|US4736752 *||28 Nov 1986||12 Abr 1988||Axelgaard Manufacturing Co., Ltd.||Transcutaneous medical electrode|
|US4763659 *||20 Ago 1986||16 Ago 1988||Spring Creek Institute, Inc.||Dry electrode system for detection of biopotentials|
|US4771783 *||3 Oct 1986||20 Sep 1988||Minnesota Mining And Manufacturing Company||Flat, conformable, biomedical electrode|
|US4830776 *||15 Sep 1986||16 May 1989||La Jolla Technology, Inc.||Adhesive composites for biomedical electrodes|
|US4865039 *||20 May 1988||12 Sep 1989||Spring Creek Institute||Dry electrode system for detection of biopotentials and dry electrode for making electrical and mechanical connection to a living body|
|US4867166 *||18 Sep 1987||19 Sep 1989||Jens Axelgaard||Electrical stimulation electrode|
|US4919148 *||13 Jun 1988||24 Abr 1990||Muccio Philip E||Apparatus and method for transcutaneous electrical stimulation|
|US4926878 *||29 Dic 1988||22 May 1990||Labeltape Meditect Inc.||Medical electrode|
|US4974917 *||3 May 1989||4 Dic 1990||Niels Kornerup||Electrode plate|
|US4989607 *||30 Mar 1989||5 Feb 1991||Preston Keusch||Highly conductive non-stringy adhesive hydrophilic gels and medical electrode assemblies manufactured therefrom|
|US4998536 *||26 Dic 1989||12 Mar 1991||Kas Products, Inc.||Defibrillator pad assembly and method for using same|
|US5003978 *||7 Sep 1989||2 Abr 1991||Technology 21, Inc.||Non-polarizable dry biomedical electrode|
|US5024227 *||29 Abr 1988||18 Jun 1991||Arbo Medizin-Technologie Gmbh||Bioelectrical electrode|
|US5038796 *||13 Abr 1989||13 Ago 1991||Axelgaard Manufacturing Co., Ltd.||Electrical stimulation electrode with impedance compensation|
|US5048540 *||15 Feb 1990||17 Sep 1991||Gerard Ramond||Contact unit embeddable in an electrically conductive casting for use in electrical treatment for therapeutical or beauty purposes|
|US5070862 *||21 Jun 1988||10 Dic 1991||Berlant Stephen R||Glove for electro-massage therapy|
|US5076286 *||2 Jul 1990||31 Dic 1991||Kas Products, Inc.||Defibrillator pad assembly and method for using same|
|US5143071 *||26 Mar 1990||1 Sep 1992||Nepera, Inc.||Non-stringy adhesive hydrophilic gels|
|US5205297 *||28 Abr 1989||27 Abr 1993||Lectec Corporation||Multipurpose medical stimulation electrode|
|US5218973 *||22 Mar 1991||15 Jun 1993||Staodyn, Inc.||Disposable wound treatment electrode|
|US5330527 *||26 Abr 1993||19 Jul 1994||Lec Tec Corporation||Multipurpose medical electrode|
|US5354790 *||31 Ago 1992||11 Oct 1994||Nepera, Inc.||Methods for the preparation of non-stringy adhesive hydrophilic gels|
|US5366489 *||8 Feb 1994||22 Nov 1994||Minnesota Mining And Manufacturing Company||Anesthesia electrode and applicator assembly|
|US5394877 *||21 Mar 1994||7 Mar 1995||Axon Medical, Inc.||Ultrasound medical diagnostic device having a coupling medium providing self-adherence to a patient|
|US5489215 *||6 Oct 1994||6 Feb 1996||Micron Medical Products, Inc.||Medical electrode|
|US5496363 *||13 Jul 1994||5 Mar 1996||Minnesota Mining And Manufacturing Company||Electrode and assembly|
|US5499628 *||27 Ago 1993||19 Mar 1996||Micron Medical Products, Inc.||Medical electrode|
|US5522878 *||26 Abr 1993||4 Jun 1996||Lectec Corporation||Solid multipurpose ultrasonic biomedical couplant gel in sheet form and method|
|US5540033 *||10 Ene 1994||30 Jul 1996||Cambrex Hydrogels||Integrated Manufacturing process for hydrogels|
|US5596038 *||16 May 1994||21 Ene 1997||Physiometrix, Inc.||Hydrogel having a silicon-based crosslinker for biosensors and electrodes|
|US5665477 *||7 Jun 1995||9 Sep 1997||Graphic Controls Corporation||Hydrogel adhesive for attaching medical device to patient|
|US5727550 *||9 Abr 1996||17 Mar 1998||Lectec Corporation||Dual purpose ultrasonic biomedical couplant pad and electrode|
|US5817016 *||28 Ago 1996||6 Oct 1998||Physiometrix, Inc.||Electrical conductor using hydrogel and method|
|US5871534 *||8 Jul 1998||16 Feb 1999||Messick; Genevieve M.||Apparatus for treating pelvic floor dysfunctions using transcutaneous electrical stimulation of the muscles|
|US5921925 *||30 May 1997||13 Jul 1999||Ndm, Inc.||Biomedical electrode having a disposable electrode and a reusable leadwire adapter that interfaces with a standard leadwire connector|
|US5928142 *||17 Dic 1996||27 Jul 1999||Ndm, Inc.||Biomedical electrode having a disposable electrode and a reusable leadwire adapter that interfaces with a standard leadwire connector|
|US6064901 *||17 Jun 1998||16 May 2000||Ndm, Inc.||Biomedical electrode having a disposable electrode and a reusable leadwire adapter that interfaces with a standard leadwire connector|
|US6076002 *||17 Jun 1998||13 Jun 2000||Ndm, Inc.||Method of manufacturing a disposable electrode|
|US6276054||8 Dic 1998||21 Ago 2001||Ndm, Inc.||Method of manufacturing a disposable electrode|
|US6285899 *||18 Feb 1999||4 Sep 2001||Motorola, Inc.||Remotely interrogated biomedical sensor|
|US6418333 *||2 Oct 2000||9 Jul 2002||Axelgaard Manufacturing Co., Ltd.||Floating electrode|
|US6643532 *||14 Jun 2002||4 Nov 2003||Axelgaard Manufacturing Co. Ltd.||Floating electrode|
|US6701172||12 Dic 2001||2 Mar 2004||3M Innovative Properties Company||Universally functional biomedical electrode|
|US7010345||26 Oct 2001||7 Mar 2006||Medtronic, Inc.||Method and apparatus to minimize effects of a cardiac insult|
|US7162291 *||1 Mar 2000||9 Ene 2007||Mirabel Medical Systems Ltd.||Uniform, disposable, interface for multi-element probe|
|US7218964||26 Oct 2001||15 May 2007||Medtronic, Inc.||Closed-loop neuromodulation for prevention and treatment of cardiac conditions|
|US7346380||16 Jun 2006||18 Mar 2008||Axelgaard Manufacturing Co., Ltd.||Medical electrode|
|US7769441||3 Nov 2005||3 Ago 2010||The Board Of Regents Of The University Of Oklahoma||Cardiac neuromodulation and methods of using same|
|US7818069 *||27 Jul 2007||19 Oct 2010||Cyberonics, Inc.||Ribbon electrode|
|US7860563||23 Nov 2005||28 Dic 2010||The Board Of Regents Of The University Of Oklahoma||Cardiac neuromodulation and methods of using same|
|US7869884||26 Abr 2007||11 Ene 2011||Cyberonics, Inc.||Non-surgical device and methods for trans-esophageal vagus nerve stimulation|
|US7904175||26 Abr 2007||8 Mar 2011||Cyberonics, Inc.||Trans-esophageal vagus nerve stimulation|
|US7962214||27 Jul 2007||14 Jun 2011||Cyberonics, Inc.||Non-surgical device and methods for trans-esophageal vagus nerve stimulation|
|US7974707||26 Ene 2007||5 Jul 2011||Cyberonics, Inc.||Electrode assembly with fibers for a medical device|
|US8005539||30 Ene 2009||23 Ago 2011||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US8121696||21 Ene 2008||21 Feb 2012||Rommel P. Vallero||Topical analgesia using electrical and vibration stimuli|
|US8180462||18 Abr 2006||15 May 2012||Cyberonics, Inc.||Heat dissipation for a lead assembly|
|US8238998 *||5 Ago 2009||7 Ago 2012||Bio Protech Inc.||Tab electrode|
|US8249708||30 Ene 2009||21 Ago 2012||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US8260412||30 Ene 2009||4 Sep 2012||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US8295946||23 May 2011||23 Oct 2012||Cyberonics, Inc.||Electrode assembly with fibers for a medical device|
|US8315713||30 Abr 2009||20 Nov 2012||Medtronic, Inc.||Techniques for placing medical leads for electrical stimulation of nerve tissue|
|US8417334||26 Oct 2001||9 Abr 2013||Medtronic, Inc.||Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions|
|US8452394||30 Ene 2009||28 May 2013||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US8473057||30 Oct 2009||25 Jun 2013||Medtronic, Inc.||Shunt-current reduction housing for an implantable therapy system|
|US8478420||12 Jul 2006||2 Jul 2013||Cyberonics, Inc.||Implantable medical device charge balance assessment|
|US8478428||23 Abr 2010||2 Jul 2013||Cyberonics, Inc.||Helical electrode for nerve stimulation|
|US8483846||8 Abr 2010||9 Jul 2013||Cyberonics, Inc.||Multi-electrode assembly for an implantable medical device|
|US8498698||31 Ago 2009||30 Jul 2013||Medtronic, Inc.||Isolation of sensing and stimulation circuitry|
|US8527045||30 Oct 2009||3 Sep 2013||Medtronic, Inc.||Therapy system including cardiac rhythm therapy and neurostimulation capabilities|
|US8532779||30 Ene 2009||10 Sep 2013||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US8532793||30 Abr 2009||10 Sep 2013||Medtronic, Inc.||Techniques for placing medical leads for electrical stimulation of nerve tissue|
|US8560060||31 Ago 2009||15 Oct 2013||Medtronic, Inc.||Isolation of sensing and stimulation circuitry|
|US8611996||30 Ene 2009||17 Dic 2013||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US8688210||30 Ene 2009||1 Abr 2014||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US8774918||30 Ene 2009||8 Jul 2014||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US8798709 *||19 Abr 2010||5 Ago 2014||Neotech Products, Inc.||Dermal sensing package and use|
|US8868203||26 Oct 2007||21 Oct 2014||Cyberonics, Inc.||Dynamic lead condition detection for an implantable medical device|
|US8931536||21 Jul 2008||13 Ene 2015||Ropheka Technologies, Llc||Devices for applying conductive gel-pads to electrodes and electrodes produced thereby|
|US8942798||26 Oct 2007||27 Ene 2015||Cyberonics, Inc.||Alternative operation mode for an implantable medical device based upon lead condition|
|US9026206||30 Oct 2009||5 May 2015||Medtronic, Inc.||Therapy system including cardiac rhythm therapy and neurostimulation capabilities|
|US9072901||23 Nov 2010||7 Jul 2015||The Board Of Regents Of The University Of Oklahoma||Cardiac neuromodulation and methods of using same|
|US9144387 *||7 Feb 2013||29 Sep 2015||Samsung Electronics Co., Ltd.||Electrode for measuring bio potential, method of manufacturing the electrode, and system for measuring physiological signal|
|US9192769||31 Ago 2009||24 Nov 2015||Medtronic, Inc.||Shunt-current reduction techniques for an implantable therapy system|
|US9561369||20 Nov 2012||7 Feb 2017||Medtronic, Inc.||Techniques for placing medical leads for electrical stimulation of nerve tissue|
|US9572982||30 Abr 2009||21 Feb 2017||Medtronic, Inc.||Techniques for placing medical leads for electrical stimulation of nerve tissue|
|US9597505||30 Ene 2009||21 Mar 2017||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US9656079||24 Sep 2009||23 May 2017||Medtronic, Inc.||Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions|
|US20020107553 *||26 Oct 2001||8 Ago 2002||Medtronic, Inc.||Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions|
|US20020143369 *||26 Oct 2001||3 Oct 2002||Medtronic, Inc.||Method and apparatus to minimize effects of a cardiac insult|
|US20030100924 *||22 Abr 2002||29 May 2003||Foreman Robert D.||Cardiac neuromodulation and methods of using same|
|US20060111745 *||3 Nov 2005||25 May 2006||Foreman Robert D||Cardiac neuromodulation and methods of using same|
|US20060111746 *||23 Nov 2005||25 May 2006||Foreman Robert D||Cardiac neuromodulation and methods of using same|
|US20070191895 *||21 Nov 2006||16 Ago 2007||Foreman Robert D||Activation of cardiac alpha receptors by spinal cord stimulation produces cardioprotection against ischemia, arrhythmias, and heart failure|
|US20070293751 *||16 Jun 2006||20 Dic 2007||Jens Axelgaard||Medical electrode|
|US20080188779 *||21 Ene 2008||7 Ago 2008||Vallero Rommel P||Topical analgesia using electrical and vibration stimuli|
|US20080269833 *||26 Abr 2007||30 Oct 2008||Cyberonics, Inc.||Trans-esophageal vagus nerve stimulation|
|US20080269834 *||27 Jul 2007||30 Oct 2008||Cyberonics Inc.||Non-Surgical Device and Methods for Trans-Esophageal Vagus Nerve Stimulation|
|US20080269840 *||26 Abr 2007||30 Oct 2008||Cyberonics, Inc.||Non-surgical device and methods for trans-esophageal vagus nerve stimulation|
|US20090030493 *||27 Jul 2007||29 Ene 2009||Colborn John C||Ribbon Electrode|
|US20090112292 *||26 Oct 2007||30 Abr 2009||Cyberonics Inc.||Dynamic lead condition detection for an implantable medical device|
|US20090125079 *||26 Oct 2007||14 May 2009||Cyberonics Inc.||Alternative operation mode for an implantable medical device based upon lead condition|
|US20090155594 *||21 Jul 2008||18 Jun 2009||Evans Thomas D||Devices for applying conductive gel-pads to electrodes and electrodes produced thereby|
|US20090275956 *||30 Abr 2009||5 Nov 2009||Medtronic, Inc.||Techniques for placing medical leads for electrical stimulation of nerve tissue|
|US20090275996 *||30 Abr 2009||5 Nov 2009||Medtronic, Inc.||Techniques for placing medical leads for electrical stimulation of nerve tissue|
|US20090276022 *||30 Abr 2009||5 Nov 2009||Medtronic , Inc.||Techniques for placing medical leads for electrical stimulation of nerve tissue|
|US20090276025 *||30 Abr 2009||5 Nov 2009||Medtronic, Inc.||Techniques for placing medical leads for electrical stimulation of nerve tissue|
|US20100016703 *||13 Jul 2007||21 Ene 2010||Cardiac Bio-Systems Inc.||Bio-electrode possessing a hydrophilic skin-contacting layer and an electrolyte substance|
|US20100056896 *||5 Ago 2009||4 Mar 2010||Bio Protech Inc.||Tab electrode and lead wire for connecting to the same|
|US20100114197 *||30 Ene 2009||6 May 2010||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US20100114198 *||30 Ene 2009||6 May 2010||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US20100114199 *||30 Ene 2009||6 May 2010||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US20100114200 *||30 Ene 2009||6 May 2010||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US20100114201 *||30 Ene 2009||6 May 2010||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US20100114202 *||30 Ene 2009||6 May 2010||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US20100114203 *||30 Ene 2009||6 May 2010||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US20100114205 *||30 Oct 2009||6 May 2010||Medtronic, Inc.||Shunt-current reduction housing for an implantable therapy system|
|US20100114208 *||30 Ene 2009||6 May 2010||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US20100114211 *||31 Ago 2009||6 May 2010||Medtronic, Inc.||Shunt-current reduction techniques for an implantable therapy system|
|US20100114217 *||30 Oct 2009||6 May 2010||Medtronic, Inc.||Therapy system including cardiac rhythm therapy and neurostimulation capabilities|
|US20100114221 *||30 Oct 2009||6 May 2010||Medtronic, Inc.||Therapy system including cardiac rhythm therapy and neurostimulation capabilities|
|US20100114224 *||30 Ene 2009||6 May 2010||Medtronic, Inc.||Implantable medical device crosstalk evaluation and mitigation|
|US20100138340 *||1 Feb 2010||3 Jun 2010||John Earl Shirey||System and apparatus for transaction fraud processing|
|US20110008739 *||7 Jul 2010||13 Ene 2011||Firestar Engineering, Llc||Detonation wave arrestor|
|US20110066200 *||23 Nov 2010||17 Mar 2011||Foreman Robert D||Cardiac neuromodulation and methods of using same|
|US20120088396 *||14 Dic 2011||12 Abr 2012||Bio Protech Inc.||Lead wire for connecting to tab electrode|
|US20130204110 *||7 Feb 2013||8 Ago 2013||Samsung Electronics Co., Ltd.||Electrode for measuring bio potential, method of manufacturing the electrode, and system for measuring physiological signal|
|CN104161507A *||29 Ago 2014||26 Nov 2014||东莞市万康医疗器械有限公司||Electrocardiogram conductive connecting line electrode|
|DE10155551A1 *||12 Nov 2001||28 May 2003||Manou Komeyli||TENS device for use in patient pain reduction, e.g. for treatment of spinal column pain, has a shaped plastic component that is worn by the patient during a normal daily routine so that medical center visits are unnecessary|
|DE10155551B4 *||12 Nov 2001||10 Feb 2005||Manou Prof. Dr. Komeyli||Vorrichtung zur transkutanen elektrischen Nervenstimulation|
|DE102011011610A1||17 Feb 2011||23 Ago 2012||Martin Mücke||Apparatus for reducing pain in human or animal body during e.g. vaccination, has electrodes that are attached to human around surgical site for reducing flux of liquid flowing through storage tube, when storage tube is fixed to human|
|EP0255241A2 *||30 Jun 1987||3 Feb 1988||Nepera, Inc.||Medical electrode|
|EP0255241A3 *||30 Jun 1987||4 Jul 1990||Nepera, Inc.||Medical electrode|
|EP0676170A1 *||4 Abr 1995||11 Oct 1995||Graphic Controls Corporation||Non-invasive fetal probe|
|EP1324693A1 *||1 Oct 2001||9 Jul 2003||Axelgaard Manufacturing Company, Inc.||Floating electrode|
|EP1324693A4 *||1 Oct 2001||27 Jul 2005||Axelgaard Mfg Company Inc||Floating electrode|
|EP2962724A1||31 Ago 2011||6 Ene 2016||Electrocore LLC||Device with enclosure for nerve modulation|
|EP2962725A1||31 Ago 2011||6 Ene 2016||Electrocore LLC||Apparatus for nerve modulation|
|WO2012110248A2||17 Feb 2012||23 Ago 2012||Muecke Martin||Device and method for reducing pain|
|Clasificación de EE.UU.||607/152, 600/395|
|Clasificación internacional||A61B5/0408, A61N1/04|
|Clasificación cooperativa||A61N1/0456, A61B5/04087, A61N1/048, A61N1/0492|
|Clasificación europea||A61N1/04E2C, A61N1/04E1N, A61N1/04E2P, A61B5/0408F|